5 Einträge gefunden

1. Faldaprevir and deleobuvir for HCV genotype 1 infection

   1. Zeuzem, Stefan
   2. Soriano, Vincent
   3. Asselah, Tarik
   4. Bronowicki, Jean-Pierre
   5. Lohse, Ansgar W
   6. Müllhaupt, Beat
   7. Schuchmann, Marcus

   2013 - Forschungsinformationssystem des UKE
2. Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results

   1. Zeuzem, Stefan
   2. Asselah, Tarik
   3. Angus, Peter
   4. Zarski, Jean-Pierre
   5. Larrey, Dominique
   6. Müllhaupt, Beat
   7. Gane, Ed

   2013 - Forschungsinformationssystem des UKE
3. Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.

   1. Zeuzem, Stefan
   2. Asselah, Tarik
   3. Angus, Peter
   4. Zarski, Jean-Pierre
   5. Larrey, Dominique
   6. Müllhaupt, Beat
   7. Gane, Ed

   2011 - Forschungsinformationssystem des UKE
4. Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

   1. Hennes, Elke
   2. Oo, Ye H
   3. Schramm, Christoph
   4. Denzer, Ulrike W.
   5. Buggisch, Peter
   6. Wiegard, Christiane
   7. Kanzler, Stephan

   2008 - Forschungsinformationssystem des UKE
5. Cutting edge: a key pathogenic role of IL-27 in T cell- mediated hepatitis.

   1. Siebler, Juergen
   2. Wirtz, Stefan
   3. Frenzel, Christian
   4. Schuchmann, Marcus
   5. Lohse, Ansgar W.
   6. Galle, Peter R
   7. Neurath, Markus F

   2008 - Forschungsinformationssystem des UKE